BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23857718)

  • 1. Mortality and morbidity hazards associated with cognitive status in seniors: a Canadian population prospective cohort study.
    Meng X; D'Arcy C
    Asia Pac Psychiatry; 2013 Sep; 5(3):175-82. PubMed ID: 23857718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year follow-up of cognitive impairment with no dementia.
    Tuokko H; Frerichs R; Graham J; Rockwood K; Kristjansson B; Fisk J; Bergman H; Kozma A; McDowell I
    Arch Neurol; 2003 Apr; 60(4):577-82. PubMed ID: 12707072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment and 7-year mortality in dialysis patients.
    Griva K; Stygall J; Hankins M; Davenport A; Harrison M; Newman SP
    Am J Kidney Dis; 2010 Oct; 56(4):693-703. PubMed ID: 20800327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does self-rated health predict dementia?
    St John P; Montgomery P
    J Geriatr Psychiatry Neurol; 2013 Mar; 26(1):41-50. PubMed ID: 23456753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study.
    Gallacher J; Bayer A; Fish M; Pickering J; Pedro S; Dunstan F; Ebrahim S; Ben-Shlomo Y
    Psychosom Med; 2009 Jul; 71(6):659-66. PubMed ID: 19553290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias.
    Hsiung GY; Donald A; Grand J; Black SE; Bouchard RW; Gauthier SG; Loy-English I; Hogan DB; Kertesz A; Rockwood K; Feldman HH
    Dement Geriatr Cogn Disord; 2006; 22(5-6):413-20. PubMed ID: 16966831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E gene, environmental risk factors, and their interactions in dementia among seniors.
    Meng X; D'Arcy C
    Int J Geriatr Psychiatry; 2013 Oct; 28(10):1005-14. PubMed ID: 23255503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are cognitively intact seniors with subjective memory loss more likely to develop dementia?
    St John P; Montgomery P
    Int J Geriatr Psychiatry; 2002 Sep; 17(9):814-20. PubMed ID: 12221654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reciprocal risks of stroke and cognitive impairment in an elderly population.
    Jin YP; Di Legge S; Ostbye T; Feightner JW; Hachinski V
    Alzheimers Dement; 2006 Jul; 2(3):171-8. PubMed ID: 19595880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality rates and predictors in community-dwelling elderly individuals with cognitive impairment: an eight-year follow-up after initial assessment.
    Park JE; Lee JY; Suh GH; Kim BS; Cho MJ
    Int Psychogeriatr; 2014 Aug; 26(8):1295-304. PubMed ID: 24965360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors in an elderly population.
    Prencipe M; Santini M; Casini AR; Pezzella FR; Scaldaferri N; Culasso F
    J Neurol; 2003 Aug; 250(8):907-12. PubMed ID: 12928907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective sleep quality in non-demented older adults with and without cognitive impairment.
    Adam AM; Potvin O; Callahan BL; Bastien C; Lorrain D; Desjardins S; Forget H; Préville M; Hudon C
    Int J Geriatr Psychiatry; 2014 Sep; 29(9):970-7. PubMed ID: 24519731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drug use and the risk of cognitive impairment and Alzheimer's disease.
    Côté S; Carmichael PH; Verreault R; Lindsay J; Lefebvre J; Laurin D
    Alzheimers Dement; 2012 May; 8(3):219-26. PubMed ID: 22546354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of Diagnoses of Cognitive Impairment, Not Dementia in a Veterans Affairs Primary Care Population.
    Holsinger T; Plassman BL; Stechuchak KM; Burke JR; Coffman CJ; Williams JW
    J Am Geriatr Soc; 2015 Jun; 63(6):1105-11. PubMed ID: 26032518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of dementia and cognitive impairment in Southeastern Spain: the Ariadna study.
    Gavrila D; Antúnez C; Tormo MJ; Carles R; García Santos JM; Parrilla G; Fortuna L; Jiménez J; Salmerón D; Navarro C
    Acta Neurol Scand; 2009 Nov; 120(5):300-7. PubMed ID: 19832772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health services utilization associated with cognitive impairment and dementia in older patients undergoing post-acute rehabilitation.
    Seematter-Bagnoud L; Martin E; Büla CJ
    J Am Med Dir Assoc; 2012 Oct; 13(8):692-7. PubMed ID: 22698955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics.
    Peters KR; Rockwood K; Black SE; Bouchard R; Gauthier S; Hogan D; Kertesz A; Loy-English I; Beattie BL; Sadovnick AD; Feldman HH
    Neurology; 2006 Feb; 66(4):523-8. PubMed ID: 16505306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia-associated mortality at thirteen years in the NEDICES Cohort Study.
    Villarejo A; Benito-León J; Trincado R; Posada IJ; Puertas-Martín V; Boix R; Medrano MR; Bermejo-Pareja F
    J Alzheimers Dis; 2011; 26(3):543-51. PubMed ID: 21694455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging.
    Ebly EM; Hogan DB; Parhad IM
    Arch Neurol; 1995 Jun; 52(6):612-9. PubMed ID: 7763211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.